Bloodstream infection test wins FDA approval

Share this article:

The Food and Drug Administration approved a test Wednesday that can help physicians diagnose an infection and select the proper antibiotic much more rapidly than with existing tests.

The Verigene GP Blood Culture Nucleic Acid Test — which is known as the BC-GP test — can identify different types of Staphylococcus, including methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus, Enterococcus (including vancomycin-resistant Enterococci) and Listeria within hours of an infection starting, Medical News Today reports. Infectious diseases such as MRSA can devastate nursing homes.

Existing bacterial tests can take up to four days to culture, which can expose patients to higher risks and lessen the effectiveness of antibiotics. Treatment of an infection with the wrong antibiotic also can result in greater antibiotic resistance, experts warn. The new BC-GP test, made by Nanosphere, offers a leap forward in catching the disease early while evaluating antibiotic resistance, the company's CEO told Medical News Today.

Share this article:

More in News

Nursing home antipsychotic use has dipped nearly 19% under national effort, latest figures show

Nursing home antipsychotic use has dipped nearly 19% ...

The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.

Jimmo succeeds in getting Medicare coverage, two years after landmark case ended

Glenda Jimmo has reached a settlement with the federal government and will finally receive Medicare coverage for claims that were denied in 2007, which led her to file a class-action lawsuit over the so-called "improvement standard."

Breier named new CEO at Kindred

Breier named new CEO at Kindred

Kindred Healthcare announced Thursday that it has chosen a new top executive to lead its push toward creating a mammoth national brand. Benjamin A. Breier, the company's current president and ...